Jiangsu Alpha Pharmaceutical Co., Ltd.

Products

tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate

    • Product Name: tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
    • Chemical Name (IUPAC): tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)ethenyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
    • CAS No.: 1369773-39-6
    • Chemical Formula: C32H34FNO4
    • Form/Physical State: Solid
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@bouling-chem.com
    • Manufacturer: Jiangsu Alpha Pharmaceutical Co., Ltd.
    • CONTACT NOW
    VTB
    Specifications
    HS Code 721594
    Iupac Name tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
    Molecular Formula C34H38FNO5
    Molecular Weight 559.67 g/mol
    Cas Number 1613220-15-7
    Appearance White to off-white solid
    Solubility Soluble in DMSO, methanol
    Smiles CC(C)(C)OC(=O)CC1C(OCC(O1)(C)C)C=CC2=CC3=C(C=C2)N=C(C4CC4)C=C3C5=CC=C(C=C5)F
    Purity Typically >98%
    Storage Conditions Store at -20°C, protected from light and moisture

    As an accredited tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle with tamper-evident cap, labeled with hazard symbols and product details; contains 5 grams of the compound.
    Container Loading (20′ FCL) 20′ FCL loaded with securely packed drums of tert-butyl 2-((4R,6S)...acetate, ensuring safe chemical transport and stability.
    Shipping This chemical will be shipped in accordance with all relevant regulations, using appropriate packaging to ensure safety and stability during transit. It will be dispatched in a sealed, labeled container, protected from light, moisture, and extreme temperatures, with a material safety data sheet (MSDS) included for safe handling and compliance purposes.
    Storage Store tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate in a cool, dry, and well-ventilated area, away from light and moisture. Keep the container tightly closed and clearly labeled. Protect from incompatible materials such as strong acids and bases, and store at recommended temperature, preferably 2–8°C, to ensure stability and prevent decomposition.
    Shelf Life Shelf life: Store at 2–8°C, protected from light and moisture; stable for at least 2 years under recommended conditions.
    Application of tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate

    Applications of tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate in Industrial Manufacturing

    As an integrated manufacturer specializing in specialty intermediates, we support advanced industry segments with high-purity tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate. Below, we outline verified downstream application scenarios, each with detailed sector-specific formulation, process, compliance, and finished product information.

    1. Pharmaceutical Active Ingredient Synthesis – Oncology Drug Intermediates

    This compound functions as a late-stage intermediate in the synthesis of targeted small molecule drugs for oncology, notably within the quinoline class developed for advanced solid tumors. API producers integrate this material during the nucleophilic addition steps that precede final deprotection and salt formation, directly impacting yield and purity of the downstream drug substance.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Small Molecule Research Chemicals – Medicinal Chemistry Building Blocks

    CROs and research organizations utilize this material as a pre-built scaffold for structure-activity relationship (SAR) exploration, particularly for anti-infective, anti-inflammatory, and rare disease screening campaigns. Its protected acetate and dioxane functionalities facilitate rapid diversification prior to compound library finalization.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Contract Manufacturing for API Process Development

    CDMOs employ this compound as a validated intermediate in route scouting and process optimization studies for eventual pharmaceutical technology transfer. Exact input percentages and solvent/temperature controls are revised according to batch size, impurity tolerances, and customer-specific process transfer guidance.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Specialty Fine Chemical Intermediate for Veterinary Drug Development

    Veterinary pharmaceutical houses require this compound as a key intermediate in the custom synthesis of novel anti-parasitic agents. In these routes, the distinctive combination of cyclopropylquinoline and fluorophenyl side chain aligns with ongoing efforts to target livestock and companion animal indications under rigorous regulatory controls.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@bouling-chem.com

    Inquiry

    Get Free Quote of Jiangsu Alpha Pharmaceutical Co., Ltd.

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate: Purpose-Driven Chemistry in Modern Synthesis

    Understanding This Molecule: A Chemist’s View

    From the workbench of daily synthesis and quality control routines to the pressure of pharmaceutical R&D schedules, every chemical compound tells a story. This one, tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate, reflects today's need for specialized building blocks that don’t just exist in a catalog but actually fit into challenging projects. Every step that leads to this molecule draws on countless hours refining process efficiency, scrutinizing purity, and tuning reactivity. From our standpoint as the manufacturer, every batch represents questions answered about impurity profiles, scalable synthesis, and product integrity.

    What sets this intermediate apart starts with the backbone: the rigid, stereocontrolled dioxane system gives pronounced selectivity to subsequent downstream chemistries. The tert-butyl ester lends operational convenience for deprotection protocols, as any experienced chemist knows, while the quinoline-quinolyl vinyl motif brings the possibility of introducing this moiety into complex aromatic frameworks. Laboratories developing new drug candidates demand this level of sophistication because off-the-shelf simplicity falls short when developing next-generation pharmaceuticals.

    Beyond the Catalog: Why Stereochemistry and Purity Matter

    Synthetic routes often live or die by stereochemical integrity. With this compound, the (4R,6S) stereochemistry and the (E)-alkene geometry are critical. Our observations on pilot-scale production confirm that once a route establishes reliable stereochemical fidelity, downstream transformations become more predictable and robust. Mistakes in controlling stereochemistry don’t just affect one project; they cascade across workflows, leading to repeated troubleshooting and lost time. In small-molecule API development, the difference between a clean intermediate and one with stereo-mixed impurities shows up in HPLC traces, purification costs, and even regulatory filings.

    Consistent purity at kilogram scale doesn’t come from luck. Every seasoned production chemist understands the rituals of solvent grading, temperature ramping, and close monitoring of reaction endpoints. The tendency of dioxane acetal groups to hydrolyze under aggressive conditions, or the lability of the vinyl side-chain during certain oxidations and reductions, all shapes how each lot is prepared and tested. Final material always gets scrutinized with NMR for conformational isomer content. LC-MS and chiral HPLC data back up every shipment because we have seen countless research groups burned by poorly characterized intermediates – sometimes losing months to faulty assumptions about what was really in the drum.

    From Bench Scale to Production Line: Real Challenges, Real Solutions

    Scaling a molecule with this level of structural complexity from grams to kilograms isn’t just about lining up bigger reactors. We ran into the notoriously tricky acetal protection-deprotection step optimization during early process development. Going from Erlenmeyer flasks to pilot tanks introduced heat transfer issues; localized warming could kick off unwanted side reactions or partially deprotect the dioxan ring, giving rise to polar by-products. Team discussions led to revisiting material addition rates and external cooling loops. Not every solution comes from textbooks – many times, it's about operators sharing tank temperature data from night shifts and lab analysts pointing out a faint spot on TLC during cleanup. Small changes, like drying sodium sulfate more thoroughly or gentle mixing at key steps, eventually push impurity levels down and throughput up.

    Repeated batch analysis helped us identify points where process robustness could slip. Storage conditions emerged as a recurring concern, especially with the tert-butyl ester under high humidity. Warehouse staff learned to inspect for early signs of hydrolysis, and even the drum liner materials saw scrutiny for leaching potential. QC teams concluded that switching to nitrogen-flushed, sealed drums trimmed down peroxide formation and protected product shelf life.

    Why Innovators Ask for This Compound by Name

    Working with academic and industrial innovators, we recognize where this intermediate typically gets used. More than once, medicinal chemists and process teams outlined their strategies using this molecule as a late-stage precursor or functional handle. It slots into syntheses targeting kinase inhibitors and other heterocycle-heavy candidates. The cyclopropyl and 4-fluorophenyl substitution patterns suit SAR (structure-activity relationship) studies, where subtle electronic tweaks steer biological activity. These distinctions matter in hit-to-lead or lead optimization phases, where rapid iteration and confident analytical data speed up decision-making.

    Compared to generic esters or more basic dioxane-protected aldehydes, this molecule brings a unique blend of physicochemical properties: the robustness to survive multi-step transformations, the solubility profile to work cleanly in mixed solvents, and the steric parameters to enforce regiocontrol in targeted coupling reactions. Peers have sometimes tried to replace it with simpler analogs, but results usually include messy product mixtures or significantly lower yields. Over the last few years, we've received feedback from teams running late-stage intermediates through continuous flow platforms, who found that the predictability and batch-to-batch consistency of this compound let them skip extensive in-line purification campaigns.

    Responsible Manufacturing and Continuous Improvement

    Operating as a direct manufacturer, every process revision exposes how seemingly minor process details – like crystallization rate or pH drift during workup – affect everything that happens downstream. The responsibility for strict material quality control doesn’t vanish at the end of the production batch; it carries over to every partner who trusts us to deliver what we promise, on the timeline their R&D schedule dictates. Investing in better inline monitoring (like FT-IR probes or PAT sensors) trimmed down deviation incidents, while in-plant process training kept teams alert to subtle shifts in how individual lots behave.

    Because environmental compliance and staff safety matter, every alteration in the synthetic plan goes through review with an eye toward solvent reduction and reduced waste output. Over time, greener solvents have replaced traditional ones in most steps. Heat-exchangers and waste solvent recycling further curb the environmental burden, even if these steps don’t earn a line on a specification sheet. Fielding technical questions from customer teams about residual solvents, genotoxic impurities, or trace metals keeps our standards sharp. Every feedback loop, whether a call from a PhD in a pharma lab or an email from QA, prompts internal review meetings and, sometimes, new process validation runs. These small system checks add up to reliability over years, not just lots.

    What Years of Manufacturing Experience Reveal

    Patterns emerge after spending years synthesizing and scaling complex intermediates. Early in our experience, minor process variables, like solvent grade or filtration speed, invited big headaches later in scale-up. Now, every kilogram ship-out gets evaluated with the collective wisdom of past mistakes folded in. Process notes on this particular compound include warnings about rapid exotherms during one Grignard addition, and real-time monitoring avoids runaway conditions. Smaller changes – using softer filtration media, or making sure all transfer lines are PTFE and not rubber – may sound trivial but spell the difference between high-purity product and costly batch rework.

    We have also seen customer R&D teams make progress using this molecule as a core synthon not just in pharmaceuticals, but also in agrochemical candidates needing robust, well-characterized advanced intermediates. Because regulators pay close attention to impurity tables and structural disclosures, the details matter everywhere from the first regulatory submission to final product launch.

    Differences from Other Advanced Intermediates

    In direct comparison with structurally similar intermediates, this tert-butyl dioxane acetate stands out for a few key reasons. The cyclopropyl-quinoline core provides a rigid, sterically demanding handle not easily mimicked by common aryl or alkenyl intermediates. Synthetically, the molecule’s reactivity profile allows selective deprotection and further derivatization, giving synthetic chemists more options in late-stage transformations. Trying to substitute a simpler allyl or methyl-ester dioxane structure leads to less control in both protection strategies and coupling steps, often triggering costly workarounds downstream.

    Working through multiple process validations and side-by-side synthesis, we've seen how this compound’s clean decomposition profile and reactivity – especially the stability of the acetal group under moderately acidic conditions – lets us push reaction windows longer or at higher concentration. This flexibility isn’t possible with less robust analogs, which may break down prematurely or turn sticky during extended reaction times. Such issues slow down multistep syntheses, eat through more purification resources, and compromise batch reliability.

    Even visual cues – like the slight pearlescence of a fresh, crystalline sample – offer clues about the underlying purity and process control. Teams that have relied on other high-order dioxane-protected compounds recognize subtle differences in color, melting point, or solubility that signal deeper process stability or, occasionally, hint at unseen side-products that more rigorous in-house controls eliminate.

    Scientific Collaboration and Knowledge Sharing

    Direct feedback from researchers using our material in scale-up trials or early-phase clinical supply has pushed refinements in how we document, test, and deliver every batch. Sharing anonymized impurity timelines, collaborating on best-practice prep for subsequent steps, and troubleshooting joint projects builds mutual confidence over contract relationships. Every year, new purification demands or process scale-outs highlight additional testing regimes or storage procedures that can edge overall process safety and reliability ahead.

    Over time, we have assembled a detailed playbook based on cumulative in-house studies, independent analytical verifications, and extensive customer input about how this intermediate behaves in complex reaction chains. These lessons make a measurable difference for chemists designing synthetic trees, especially when adapting reaction conditions from literature to kilo-lab or production scale, where textbook conditions often fall short. Experienced chemists recognize that reliable access to high-purity, stereochemically defined intermediates can speed up not just one project, but lay the groundwork for future synthesis campaigns.

    Future of Advanced Intermediates in Targeted Synthesis

    As new synthetic challenges crop up in pharma and allied industries, the expectations for advanced intermediates keep rising. Regulatory scrutiny, demand for greener, safer processes, and the push for time-to-market means there is little margin for inconsistency. Intermediates like tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate end up doing more than just filling a slot in a synthetic route: they serve as stress tests for everything from analytical rigor to storage logistics.

    Customers expect more today than a simple COA stapled to the shipment paperwork. They want access to in-house technical staff for troubleshooting, batch traceability right down to raw material origins, and data on every relevant impurity that could impact final outcomes. We keep documentation transparent and review every new query or non-standard request seriously, because building long-term trust comes from demonstrating knowledge and providing reliable solutions consistently. If a regulatory environment or therapeutic goal evolves, our approach adapts as well.

    The feedback loop between hands-on chemistry and product delivery never closes. By continuously reviewing project outcomes and collecting stories from real users, we keep improving both process and service. Over the years, advancing from gram-scale research syntheses to complex manufacturing lines has given us the insight to understand where scientific specification meets real-world needs – and how to avoid the pitfalls of mere shelf-stock chemistry.

    Final Reflections from the Manufacturing Floor

    Every kilogram of tert-butyl 2-((4R,6S)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate leaving the plant carries with it not just a label and a lot number, but years of accumulated knowledge. Each process hitch, analytical challenge, or quality review adds to our understanding of what sets a truly reliable chemical supplier apart. Our approach, born of hands-on experience, balances process innovation with careful risk management, always paying attention to the real-world pressures that our partners face every day.

    For any research or production team aiming to reach peak process dependability, choosing the right intermediate makes all the difference. By focusing on what makes this molecule distinct – both in structure and in the discipline of its manufacture – we support not just present projects, but also the development initiatives and scientific goals of the future. Feedback from the field keeps pointing us forward, and every challenge met ensures the next shipment sets a new standard in chemical reliability.